271
|
|
|
3-hydroxy-3-methylglutaryl-CoA lyase |
HL, HMGCL1 |
|
272
|
|
|
3-hydroxy-3-methylglutaryl-CoA lyase like 1 |
ERCHL, bA418P12.1, er-cHL |
|
273
|
|
|
3-hydroxy-3-methylglutaryl-CoA reductase |
LDLCQ3, LGMDR28, MYPLG |
Alzheimer disease, Angina pectoris, Ankylosing spondylitis, Asthma, Atrial fibrillation, Attention deficit hyperactivity disorder, Autoimmune disease, Autoinflammatory syndrome, Limb girdle muscular dystrophy, Cancer, Hepatocellular carcinoma, Cardiovascular disease, Cholecystolithiasis, Ischemic heart disease, Coronary artery disease, Mevalonate kinase deficiency, Diabetes mellitus, Diabetes mellitus type 2, Hyperlipidemia, Gallstones, Heart failure, Hypercholesterolemia, Hyper-immunoglobulin d syndrome, Hyperlipoproteinemia, Kidney failure, Limb-girdle muscular dystrophy, Liver cirrhosis, Metabolic syndrome, Muscular dystrophy, Myocardial infarction, Myocardial ischemia, Myopathy, Parkinson disease, Schizophrenia, StrokeView all (20 more) |
274
|
|
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
HMGCS |
|
275
|
|
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
- |
|
276
|
|
|
High mobility group nucleosome binding domain 1 |
HMG14 |
|
277
|
|
|
High mobility group nucleosomal binding domain 2 |
HMG17 |
|
278
|
|
|
High mobility group nucleosomal binding domain 4 |
HMG17L3, NHC |
Alzheimer disease, Autism, Cannabis abuse, Dental caries, Inflammatory bowel disease, Irritable bowel syndrome, Lung cancer, Major depressive disorder, Multiple sclerosis, Post-traumatic stress disorder, Psoriasis, Rheumatoid arthritis, Schizophrenia, Small cell lung carcinoma, Upper aerodigestive tract neoplasm |
279
|
|
|
High mobility group nucleosome binding domain 5 |
NBP-45, NSBP1 |
|
280
|
|
|
HMG-box containing 3 |
HMGX3, SMF |
|